Wednesday, 26 August 2026European Markets

STEF Stock Was Up By 9.63% Before The Weekend

Loading stream...

(vianews) - the market ended the session with stef (stf.pa) rising 9.63% to €136.60 on friday, following the last session's downward trend. cac 40 rose 0.15% to €8,028.01, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

stef's last close was €124.60, 0.16% higher than its 52-week high of €124.40.

about stef

stef sa provides temperature-controlled road transport and logistics services for agri-food industry, and out-of-home foodservices. it transports fresh, frozen, and thermosensitive products; and seafood products. the company also provides maritime passenger and freight transport services between marseille and corsica; and co-packing services. it operates in france, italy, spain, portugal, belgium, the netherlands, switzerland, and the united kingdom. the company was founded in 1920 and is headquartered in paris, france.

earnings per share

as for profitability, stef has a trailing twelve months eps of €14.05.

pe ratio

stef has a trailing twelve months price to earnings ratio of 9.72. meaning, the purchaser of the share is investing €9.72 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.17%.

sales growth

stef's sales growth for the current quarter is negative 2.6%.

volume

today's last reported volume for stef is 6526 which is 307.36% above its average volume of 1602.

more news about stef (stf.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com